Trials / Conditions / Angiomatoid Fibrous Histiocytoma
Angiomatoid Fibrous Histiocytoma
5 registered clinical trials studyying Angiomatoid Fibrous Histiocytoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation The NCT06239272 | St. Jude Children's Research Hospital | Phase 1 / Phase 2 |
| Unknown | A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) NCT05266196 | Salarius Pharmaceuticals, LLC | Phase 1 / Phase 2 |
| Completed | Angiomatoid Fibrous Histiocytoma: a Single Institution Case-series NCT03759327 | Istituto Ortopedico Rizzoli | — |
| Unknown | Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcom NCT03600649 | Salarius Pharmaceuticals, LLC | Phase 1 |
| Active Not Recruiting | Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients Wi NCT02180867 | National Cancer Institute (NCI) | Phase 2 / Phase 3 |